secwatch.observer — SEC 8-K summary
======================================

Issuer:     STRATA Skin Sciences, Inc. (SSKN)
CIK:        0001051514
Form:       8-K
Filed at:   2025-08-07T23:59:59+00:00
Accession:  0001140361-25-029355
Event type: regulatory
Sentiment:  positive
Materiality: 0.70
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Strata seeks CMS temporary codes for expanded XTRAC reimbursement; triples addressable market to 30M+
--------------------------------------------------------------------------------

- Working with CMS to secure temporary codes for expanded CPT codes for XTRAC, aiming for 2026 reimbursement instead of 2027.
- Expanded coding triples addressable patient population to over 30M for inflammatory and autoimmune skin conditions.
- Two new studies show excimer laser plus JAK inhibitors safe and effective for vitiligo, supporting XTRAC use.
- Federal court adds LaserOptek Korea and C. Dalton as defendants in false advertising lawsuit; STRATA encouraged by ruling.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1051514/000114036125029355/0001140361-25-029355-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1051514/000114036125029355/ef20053379_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-25-029355

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer